Colgate-Palmolive (NYSE:CL) Shares Bought by Oak Thistle LLC

Oak Thistle LLC grew its stake in Colgate-Palmolive (NYSE:CL) by 169.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,284 shares of the company’s stock after buying an additional 10,861 shares during the quarter. Oak Thistle LLC’s holdings in Colgate-Palmolive were worth $1,571,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Wealthspire Advisors LLC grew its stake in Colgate-Palmolive by 3.0% in the 2nd quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after acquiring an additional 111 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in Colgate-Palmolive by 2.5% during the second quarter. Oppenheimer Asset Management Inc. now owns 27,860 shares of the company’s stock valued at $2,704,000 after purchasing an additional 678 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of Colgate-Palmolive by 16.2% in the second quarter. Envestnet Asset Management Inc. now owns 459,445 shares of the company’s stock valued at $44,585,000 after purchasing an additional 64,123 shares during the period. Angeles Investment Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the second quarter worth about $242,000. Finally, Dimensional Fund Advisors LP raised its position in shares of Colgate-Palmolive by 19.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,503,450 shares of the company’s stock worth $340,006,000 after purchasing an additional 565,524 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $87.73 on Wednesday. The business’s 50-day simple moving average is $92.36 and its 200 day simple moving average is $97.92. The company has a market cap of $71.68 billion, a P/E ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.37% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently commented on CL. Piper Sandler dropped their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $103.63.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.